chr6-36963324-G-A
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_153370.3(PI16):c.982G>A(p.Val328Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000905 in 1,614,034 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_153370.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PI16 | NM_153370.3 | c.982G>A | p.Val328Met | missense_variant | 5/7 | ENST00000373674.4 | NP_699201.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PI16 | ENST00000373674.4 | c.982G>A | p.Val328Met | missense_variant | 5/7 | 1 | NM_153370.3 | ENSP00000362778.3 | ||
PI16 | ENST00000611814.4 | c.982G>A | p.Val328Met | missense_variant | 6/8 | 5 | ENSP00000478888.1 | |||
PI16 | ENST00000647861.1 | c.982G>A | p.Val328Met | missense_variant | 7/9 | ENSP00000497550.1 | ||||
PI16 | ENST00000491324.1 | n.44+291G>A | intron_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.0000789 AC: 12AN: 152150Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000955 AC: 24AN: 251412Hom.: 0 AF XY: 0.000110 AC XY: 15AN XY: 135914
GnomAD4 exome AF: 0.0000917 AC: 134AN: 1461884Hom.: 0 Cov.: 32 AF XY: 0.0000839 AC XY: 61AN XY: 727242
GnomAD4 genome AF: 0.0000789 AC: 12AN: 152150Hom.: 0 Cov.: 32 AF XY: 0.0000807 AC XY: 6AN XY: 74314
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 22, 2023 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at